Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
AMRI

January 13, 2009
Junan Guo, Ph.D. has been appointed senior director, analytical and quality services, AMRI. Dr. Guo replaces Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008. Dr. Guo will overs…  Read More »
PRA Expands Trial Capabilities in Asia

January 13, 2009
PRA Taiwan, a subsidiary of PRA International, has entered a strategic partnership with LSK Global Pharma Services and Mediscience Planning for the joint management of multinational clinical trials in Asia as well as related services, such as study m…  Read More »
BMS, ZymoGenetics Enter Global Hep-C Pact

January 13, 2009
Bristol-Myers Squibb and ZymoGenetics, Inc. entered a global collaboration for PEG-Interferon lambda, a novel type 3 interferon currently in Phase Ib development for the treatment of Hepatitis C, and its related development program. Under the term…  Read More »
Wyeth, Santaris Pharma Enter RNA Alliance

January 12, 2009
Wyeth and Santaris Pharma have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris' Locked Nucleic Acid (LNA) drug platform, which allows specific targeting and regulation of microRNAs (m…  Read More »
Boehringer Ingelheim

January 12, 2009
Albert Ros has been appointed executive vice president of sales and marketing for Boehringer Ingelheim's prescription medicines business. In his new role, Mr. Ros will lead the U.S. sales and marketing strategy of the company's core brands. "…  Read More »
EpiCept Ceases Drug Discovery Operations, Cuts Workforce

January 12, 2009
EpiCept Corp. is discontinuing all drug discovery activities and reducing its workforce by approximately 65%. These actions are expected to reduce annual expenses by at least $5.5 million. EpiCept will direct its resources toward the registration of…  Read More »
XDx, BMS Enter Biomarker Pact

January 9, 2009
XDx, Inc. has signed a collaborative pharmacogenomics agreement with Bristol-Myers Squibb focused on identifying biomarkers for Systemic Lupus Erythematosus (SLE) for clinical diagnostic purposes associated with the development of BMS' rheumatoid art…  Read More »
Almac Clinical Technologies Expands Headquarters

January 9, 2009
Almac Clinical Technologies has added 6,000 sq. ft. of space at its Yardley, PA headquarters. The expansion is part of the company’s strategy to provide an environment that "spurs innovation, high quality project management, and customer s…  Read More »
GSK Resubmits Solzira NDA

January 9, 2009
GlaxoSmithKline and development partner XenoPort have resubmitted the NDA to the FDA requesting approval of Solzira Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).   The FDA requested that…  Read More »
Tekmira Gets $11.2M Commitment from Alnylam

January 8, 2009
Tekmira Pharmaceuticals expects to receive $11.2 million during the next three years from partner Alnylam Pharmaceuticals for process development and manufacturing services. This commitment is part of the company's manufacturing pact with Alnylam for…  Read More »
Crucell, Wyeth Discuss Acquisition

January 8, 2009
Crucell N.V. is in preliminary discussions with Wyeth for the purchase of the Dutch vaccine company in a transaction valued at nearly $1.4 billion. In a statement, Crucell confirmed the talks, saying it is in "friendly discussions with Wyeth tha…  Read More »
UPS To Manage Merck's U.S. Distribution

January 8, 2009
UPS has been selected by Merck to manage a significant portion of its U.S. distribution of pharmaceuticals and vaccines as well as to provide package transportation services. Through its subsidiary, UPS Supply Chain Solutions, UPS has assumed control…  Read More »
Keata Signs Consumer Supply Pact

January 7, 2009
Keata Pharma, a subsidiary of PharmEng International, has signed an agreement with an undisclosed global consumer healthcare company for the manufacture of branded non-prescription drug products for Canada and other international territories. This ne…  Read More »
Akrimax Enters Manufacturing Pact

January 7, 2009
Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009.       Akrimax president Alan L. Rubino…  Read More »
MDS Pharma Services

January 7, 2009
Rudy Howard has been named senior vice president and chief financial officer, MDSPS. Mr. Howard has experience as a senior financial executive in the pharmaceutical and CRO industry sectors, including six years as chief financial officer at Pharmaceu…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: